Volume 7, Issue 1, Pages (July 1997)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 6, Pages (June 2001)
Advertisements

Volume 114, Issue 4, Pages (April 1998)
MHC class II/CD38/CD9: a lipid-raft–dependent signaling complex in human monocytes by Marie-Thérèse Zilber, Niclas Setterblad, Thierry Vasselon, Christelle.
Volume 9, Issue 5, Pages (November 1998)
Regulation of FcεRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells by Kiyonao Sada, S. M. Shahjahan Miah, Koichiro.
by Koji Nakamura, Alexander Malykhin, and K. Mark Coggeshall
Vanessa L. Ott, PhD, Dana C. Fong, PhD, John C. Cambier, PhD 
Christopher L. Kepley, PhD, Bridget S. Wilson, PhD, Janet M
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1- Related Immune Thrombocytopenia  Michael Nardi, Stephen Tomlinson, M.Alba.
Volume 26, Issue 3, Pages (March 2007)
Volume 34, Issue 6, Pages (June 2011)
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac by Alice Y. Pollitt, Beata Grygielska, Bertrand.
Volume 11, Issue 3, Pages (September 1999)
Phosphatidylinositol 3-Kinase/Akt-Dependent and -Independent Protection Against Apoptosis in Normal Human Melanocytes  Masahiro Oka, Akiko Kageyama, Mizuho.
Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties by Frederick D. Goldman, Andrew L. Gilman,
Rapid ubiquitination of Syk following GPVI activation in platelets
BLNK Immunity Volume 9, Issue 1, Pages (July 1998)
Activation of Phosphoinositide 3-Kinase γ by Ras
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 24, Issue 5, Pages (May 2006)
CD22 is a negative regulator of B-cell receptor signalling
Silvia Bolland, Roger N Pearse, Tomohiro Kurosaki, Jeffrey V Ravetch 
BTK Regulates PtdIns-4,5-P2 Synthesis
Loss of syk kinase during IgE-mediated stimulation of human basophils
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Volume 4, Issue 2, Pages (February 1996)
Manfred Kraus, Kaoru Saijo, Raul M Torres, Klaus Rajewsky  Immunity 
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
Regulation of BCR Signal Transduction in B-1 Cells Requires the Expression of the Src Family Kinase Lck  Joseph M. Dal Porto, Kathy Burke, John C. Cambier 
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 
Volume 7, Issue 1, Pages (July 1997)
Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431 
A Role for Ran-GTP and Crm1 in Blocking Re-Replication
Christopher L. Kepley, PhDa, John C. Cambier, PhDb, Penelope A
Volume 11, Issue 5, Pages (November 1999)
Volume 61, Issue 5, Pages (May 2002)
Siqi Lin, Claudia Cicala, Andrew M Scharenberg, Jean-Pierre Kinet  Cell 
Negative Selection of Immature B Cells by Receptor Editing or Deletion Is Determined by Site of Antigen Encounter  Peter C Sandel, John G Monroe  Immunity 
Volume 86, Issue 5, Pages (September 1996)
Volume 6, Issue 4, Pages (October 2000)
BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells
Volume 8, Issue 14, Pages (July 1998)
Volume 8, Issue 4, Pages (October 2005)
Silva H Hanissian, Raif S Geha  Immunity 
Volume 11, Issue 2, Pages (August 1999)
LAT Links the Pre-BCR to Calcium Signaling
Volume 32, Issue 2, Pages (February 2010)
Identification of Anergic B Cells within a Wild-Type Repertoire
Volume 13, Issue 1, Pages (July 2000)
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Anu Cherukuri, Paul C. Cheng, Hae Won Sohn, Susan K. Pierce  Immunity 
Volume 15, Issue 6, Pages (December 2001)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 15, Issue 5, Pages (November 2001)
RhoA GTPase Regulates B Cell Receptor Signaling
Volume 12, Issue 3, Pages (March 2000)
Volume 7, Issue 6, Pages (December 1997)
Volume 31, Issue 5, Pages (November 2009)
Suman Paul, Anuj K. Kashyap, Wei Jia, You-Wen He, Brian C. Schaefer 
Volume 28, Issue 1, Pages (January 2008)
Volume 23, Issue 2, Pages (August 2005)
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
SLP-76 Regulates Fcγ Receptor and Integrin Signaling in Neutrophils
Epstein–Barr Virus Coopts Lipid Rafts to Block the Signaling and Antigen Transport Functions of the BCR  Michelle L Dykstra, Richard Longnecker, Susan.
Volume 14, Issue 6, Pages (June 2001)
Presentation transcript:

Volume 7, Issue 1, Pages 49-58 (July 1997) FcγRIIB1 Inhibition of BCR-Mediated Phosphoinositide Hydrolysis and Ca2+ Mobilization Is Integrated by CD19 Dephosphorylation  Keli L Hippen, Anne Mette Buhl, Daniele D'Ambrosio, Kazuhiro Nakamura, Christoph Persin, John C Cambier  Immunity  Volume 7, Issue 1, Pages 49-58 (July 1997) DOI: 10.1016/S1074-7613(00)80509-9

Figure 1 Effect of FcγRIIB1 Coligation on BCR-Mediated Tyrosine Phosphorylation A20 and IIA1.6 (a FcγRIIB1 negative variant of A20) B lymphoma cells were cultured without stimulus (-) or were stimulated with intact (I) or F(ab′)2 (F) fragments of rabbit antibody to mouse immunoglobulin (BCR). (A) Anti-phosphotyrosine immunoblots of A20 and IIA1.6 lysates (1 × 106 cell equivalents) of cells cultured with and without stimulation for 2 min. (B) Anti-phosphotyrosine immunoblots of CD19, Vav, and Igα immunoprecipitates from A20 and IIA1.6 cells (20 × 106), stimulated for various time periods (0–300 sec). (C) Representation of the tyrosine phosphorylation of CD19, Igα, Igβ, PLCγ2, Lyn, Syk, and Vav isolated from A20 and IIA1.6 cell lysates normalized to the amount of effector present in the sample determined by immunoblotting. Data are representative of three independent experiments. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)

Figure 1 Effect of FcγRIIB1 Coligation on BCR-Mediated Tyrosine Phosphorylation A20 and IIA1.6 (a FcγRIIB1 negative variant of A20) B lymphoma cells were cultured without stimulus (-) or were stimulated with intact (I) or F(ab′)2 (F) fragments of rabbit antibody to mouse immunoglobulin (BCR). (A) Anti-phosphotyrosine immunoblots of A20 and IIA1.6 lysates (1 × 106 cell equivalents) of cells cultured with and without stimulation for 2 min. (B) Anti-phosphotyrosine immunoblots of CD19, Vav, and Igα immunoprecipitates from A20 and IIA1.6 cells (20 × 106), stimulated for various time periods (0–300 sec). (C) Representation of the tyrosine phosphorylation of CD19, Igα, Igβ, PLCγ2, Lyn, Syk, and Vav isolated from A20 and IIA1.6 cell lysates normalized to the amount of effector present in the sample determined by immunoblotting. Data are representative of three independent experiments. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)

Figure 1 Effect of FcγRIIB1 Coligation on BCR-Mediated Tyrosine Phosphorylation A20 and IIA1.6 (a FcγRIIB1 negative variant of A20) B lymphoma cells were cultured without stimulus (-) or were stimulated with intact (I) or F(ab′)2 (F) fragments of rabbit antibody to mouse immunoglobulin (BCR). (A) Anti-phosphotyrosine immunoblots of A20 and IIA1.6 lysates (1 × 106 cell equivalents) of cells cultured with and without stimulation for 2 min. (B) Anti-phosphotyrosine immunoblots of CD19, Vav, and Igα immunoprecipitates from A20 and IIA1.6 cells (20 × 106), stimulated for various time periods (0–300 sec). (C) Representation of the tyrosine phosphorylation of CD19, Igα, Igβ, PLCγ2, Lyn, Syk, and Vav isolated from A20 and IIA1.6 cell lysates normalized to the amount of effector present in the sample determined by immunoblotting. Data are representative of three independent experiments. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)

Figure 2 BCR Ligation–Dependent p85 Association with CD19 Is Prevented by FcγRIIB1 Coligation A20 cells (50 × 106 ml/sample) were cultured without stimulus (-) or were stimulated with intact (I) or F(ab′)2 (F) rabbit antibody to mouse immunoglobulin (BCR) (50 or 32 μg/ml, respectively) for 2 min. (A) The cells were lysed in 1% NP-40 and CD19 or p85 immunoprecipitated. The immunoprecipitates were washed, eluted with SDS reducing sample buffer, fractionated by SDS-PAGE on a 10% gel, and transferred to Immobilon-P membranes. The membranes were sequentially immunoblotted with anti-CD19 and anti-p85. (B) Coprecipitation of PI3K activity with CD19 was assessed from A20 cells (10 × 106) that were stimulated and lysed as above. CD19 immunoprecipitates were washed and analyzed for PI3K activity as described. Data are representative of three experiments. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)

Figure 3 Inhibition of BCR-Mediated IP3 Production and Ca2+ Mobilization, but Not CD19 Tyrosine Phosphorylation, by the PI3K Inhibitor Wortmannin (A) A20 cells (12 × 106/0.4 ml/sample) were stimulated with F(ab′)2 (12.8 μg) or intact (20 μg) rabbit anti-mouse IgG (RAMIG) in vehicle alone (0.2% dimethylsulfoxide [DMSO]) or with F(ab′)2 plus 10 nM wortmannin in 0.2% DMSO (added 30 min prior to stimulation). At the times indicated, cells were harvested and lysed, and cellular IP3 concentrations assayed. The results are shown as fold stimulation above resting levels of 1.41 pmol/sample. Results are representative of four replicate experiments. (B) A20 cells (1 × 106/ml/sample) were loaded with Indo-1 AM and stimulated with either F(ab′)2 (12.8 μg/ml) or intact (20 μg/ml) rabbit anti-mouse IgG. Shown is mean [Ca2+]i in cells stimulated with intact rabbit anti-mouse IgG antibody, F(ab′)2 fragments after preincubation of cells for 30 min with DMSO (vehicle alone 0.2%), or with 25 nM wortmannin in DMSO. Shown is the mean of the entire population based on analysis of approximately 900 cells/second. (C) Equivalent analysis of cells as in (B) above after suspension in 60 nM [Ca2+]0 buffered medium followed by repletion of ambient Ca2+ to 1.3 mM. (D) A20 cells (20 × 106/1 ml/sample) were cultured for 30 min with either DMSO alone (− wortmannin) or with 25 nM wortmannin in DMSO (+ wortmannin). Cells were left unstimulated (−) or were stimulated with intact (I) or F(ab′)2 (F) rabbit anti-mouse Ig antibody (50 or 32 μg/ml, respectively) for 2 min and lysed and CD19 immunoprecipitated using specific antibodies. The immunoprecipitates were washed, fractionated by SDS-PAGE, transferred to Immobilon-P membranes, and immunoblotted sequentially with anti-phosphotyrosine (not shown) and anti-CD19 antibodies. Data are representative of two independent experiments. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)

Figure 3 Inhibition of BCR-Mediated IP3 Production and Ca2+ Mobilization, but Not CD19 Tyrosine Phosphorylation, by the PI3K Inhibitor Wortmannin (A) A20 cells (12 × 106/0.4 ml/sample) were stimulated with F(ab′)2 (12.8 μg) or intact (20 μg) rabbit anti-mouse IgG (RAMIG) in vehicle alone (0.2% dimethylsulfoxide [DMSO]) or with F(ab′)2 plus 10 nM wortmannin in 0.2% DMSO (added 30 min prior to stimulation). At the times indicated, cells were harvested and lysed, and cellular IP3 concentrations assayed. The results are shown as fold stimulation above resting levels of 1.41 pmol/sample. Results are representative of four replicate experiments. (B) A20 cells (1 × 106/ml/sample) were loaded with Indo-1 AM and stimulated with either F(ab′)2 (12.8 μg/ml) or intact (20 μg/ml) rabbit anti-mouse IgG. Shown is mean [Ca2+]i in cells stimulated with intact rabbit anti-mouse IgG antibody, F(ab′)2 fragments after preincubation of cells for 30 min with DMSO (vehicle alone 0.2%), or with 25 nM wortmannin in DMSO. Shown is the mean of the entire population based on analysis of approximately 900 cells/second. (C) Equivalent analysis of cells as in (B) above after suspension in 60 nM [Ca2+]0 buffered medium followed by repletion of ambient Ca2+ to 1.3 mM. (D) A20 cells (20 × 106/1 ml/sample) were cultured for 30 min with either DMSO alone (− wortmannin) or with 25 nM wortmannin in DMSO (+ wortmannin). Cells were left unstimulated (−) or were stimulated with intact (I) or F(ab′)2 (F) rabbit anti-mouse Ig antibody (50 or 32 μg/ml, respectively) for 2 min and lysed and CD19 immunoprecipitated using specific antibodies. The immunoprecipitates were washed, fractionated by SDS-PAGE, transferred to Immobilon-P membranes, and immunoblotted sequentially with anti-phosphotyrosine (not shown) and anti-CD19 antibodies. Data are representative of two independent experiments. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)

Figure 4 CD19 Expression Is Required for Normal BCR-Mediated Ca2+ Mobilization and for FcγRIIB-Mediated Inhibition of BCR- Mediated Calcium Mobilization Dense B cells from CD19+/+ and CD19−/− mice were loaded with Indo-1 AM, and [Ca2+]i was analyzed by flow cytometry under the following conditions: (A) CD19+/+ and CD19−/− (1 × 106 cells/ml) cells in 1.3 mM [Ca2+]0 were stimulated with F(ab′)2 rabbit anti-mouse IgG (12.8 μg/ml) at the indicated time point (arrow). CD19+/+ (B) or CD19−/− (C) B cells (1 × 106/ml) were stimulated with rabbit anti-mouse IgG antibodies (20 μg/ml) or F(ab′)2 fragments of the same antibody (12.8 μg/ml) at the indicated time point (arrow). Results are representative of analysis of cells from four individual CD19−/− mice and four individual CD19+/+ mice. Shown is the mean [Ca2+]i based on analysis of approximately 900 cells/sec. Immunity 1997 7, 49-58DOI: (10.1016/S1074-7613(00)80509-9)